EMPLOYMENT AGREEMENT (Jyrki Matilla, M.D., Ph.D.)Employment Agreement • June 18th, 2004 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations • Pennsylvania
THIS EMPLOYMENT AGREEMENT (the “Agreement”) entered into as of April 19, 2004, by and between Auxilium Pharmaceuticals, Inc. (the “Company”) and Jyrki Matilla, M.D., Ph.D. (“Executive”).
MASTER SECURITY AGREEMENT dated as of June 16, 2002 (“Agreement”)Master Security Agreement • June 18th, 2004 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations
THIS AGREEMENT is between General Electric Capital Corporation (together with its successors and assigns, if any, “Secured Party”) and Auxilium Pharmaceuticals, Inc. (“Debtor”). Secured Party has an office at 401 Merritt 7 Suite 23, Norwalk, CT 06851-1177. Debtor is a corporation organized and existing under the laws of the state of Delaware. Debtor’s mailing address and chief place of business is Auxilium Pharmaceuticals, 160 W. Germantown Pike, Norristown, PA 19401.
DEVELOPMENT AND LICENSE AGREEMENT dated as of June 3, 2004 by and between BIOSPECIFICS TECHNOLOGIES CORP. (a Delaware corporation) and AUXILIUM PHARMACEUTICALS, INC. (a Delaware corporation)Development and License Agreement • June 18th, 2004 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations • New York
This DEVELOPMENT AND LICENSE AGREEMENT (this “Agreement”) dated the 3rd day of June, 2004 (the “June 3, 2004”) is by and between BioSpecifics Technologies Corp., a corporation organized and existing under the laws of Delaware and having its principal office at 35 Wilbur Street, Lynbrook, New York 11563, and its Affiliates (“BTC”), and Auxilium Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 160 West Germantown Pike, Norristown, PA 19401(“Auxilium”). BTC and Auxilium shall sometimes be referred to herein individually as a “Party” and collectively as “Parties.”
AMENDMENT TO LICENSE AGREEMENTLicense Agreement • June 18th, 2004 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Amendment to License Agreement (the “Amendment”) is entered into as of April 19, 2004 (“Effective Date”) by and between Formulation Technologies, L.L.C., a Texas limited liability company, d/b/a PharmaForm with offices at 1006 East Yager Lane, Building D, Suite 101, Austin, Texas 78753 (hereinafter, “Licensor”), and Auxilium Pharmaceuticals, Inc., a Delaware corporation having a principal place of business at 160 W. Germantown Pike, East Norriton, Pennsylvania 19401 (hereinafter “Licensee”).
